Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 1
2018 1
2019 1
2020 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer.
Papadaki MA, Koutsopoulos AV, Tsoulfas PG, Lagoudaki E, Aggouraki D, Monastirioti A, Koutoulaki C, Apostolopoulou CA, Merodoulaki AC, Papadaki C, Mavroudis D, Agelaki S. Papadaki MA, et al. Among authors: koutoulaki c. Cancers (Basel). 2020 Feb 6;12(2):376. doi: 10.3390/cancers12020376. Cancers (Basel). 2020. PMID: 32041353 Free PMC article.
MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells.
Tsitoura E, Wells AU, Karagiannis K, Lasithiotaki I, Vasarmidi E, Bibaki E, Koutoulaki C, Sato H, Spandidos DA, Siafakas NM, Sourvinos G, Antoniou KM. Tsitoura E, et al. Among authors: koutoulaki c. Oncotarget. 2016 Nov 15;7(46):74569-74581. doi: 10.18632/oncotarget.12740. Oncotarget. 2016. PMID: 27769060 Free PMC article.
Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the IdyllaTM platform: a real-world two-center experience in Greece.
Michaelidou K, Karniadakis I, Pantelaion V, Koutoulaki C, Boukla E, Folinas K, Dimaras P, Papadaki MA, Koutsopoulos AV, Mavroudis D, Vourlakou C, Mavridis K, Agelaki S. Michaelidou K, et al. Among authors: koutoulaki c. Expert Rev Mol Diagn. 2024 Jan-Feb;24(1-2):89-98. doi: 10.1080/14737159.2024.2303320. Epub 2024 Jan 11. Expert Rev Mol Diagn. 2024. PMID: 38193169
miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns.
Bibaki E, Tsitoura E, Vasarmidi E, Margaritopoulos G, Trachalaki A, Koutoulaki C, Georgopoulou T, Spandidos DA, Tzanakis N, Antoniou KM. Bibaki E, et al. Among authors: koutoulaki c. Mol Med Rep. 2018 May;17(5):7105-7112. doi: 10.3892/mmr.2018.8778. Epub 2018 Mar 19. Mol Med Rep. 2018. PMID: 29568927 Free PMC article.
Aberrant expression of miR-21, miR-376c and miR-145 and their target host genes in Merkel cell polyomavirus-positive non-small cell lung cancer.
Lasithiotaki I, Tsitoura E, Koutsopoulos A, Lagoudaki E, Koutoulaki C, Pitsidianakis G, Spandidos DA, Siafakas NM, Sourvinos G, Antoniou KM. Lasithiotaki I, et al. Among authors: koutoulaki c. Oncotarget. 2016 Aug 11;8(68):112371-112383. doi: 10.18632/oncotarget.11222. eCollection 2017 Dec 22. Oncotarget. 2016. PMID: 29348831 Free PMC article.